On Thursday, the American Society of Gene & Cell Therapy (ASGCT) and the Orphan Therapeutics Accelerator (OTXL) debuted a joint clearinghouse for shelved drug programs
BOSTON — Two nonprofit organizations have devised a plan to help abandoned cell and gene therapies find a new home.
On Thursday, the American Society of …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Astellas treatment offers new hope to a devastated rare disease community
Five years after disaster, a rare disease community gets new chance at treatment
Integrated CDO capabilities reduce early development complexity
BeOne wins FDA approval in lymphoma race
Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
FDA floats possible approach to repurpose approved drugs under new uses
Drug meant to make gene therapy safer may also make it less effective
CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
Gene therapy viruses linked to a boy's tumor
